DIMENSIONAL FUND ADVISORS LP - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 35 filers reported holding PSYCHEMEDICS CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$151,591
-40.8%
38,184
-32.0%
0.00%
Q2 2023$256,067
-13.8%
56,155
-0.7%
0.00%
Q1 2023$296,951
+102296.9%
56,562
-4.0%
0.00%
Q4 2022$290
-99.9%
58,916
+0.3%
0.00%
Q3 2022$379,0000.0%58,726
-1.8%
0.00%
Q2 2022$379,000
-9.5%
59,829
-0.8%
0.00%
Q1 2022$419,000
-3.7%
60,307
-3.8%
0.00%
Q4 2021$435,000
-32.9%
62,658
-17.8%
0.00%
Q3 2021$648,000
-18.8%
76,181
-33.5%
0.00%
Q2 2021$798,000
+20.0%
114,623
+6.9%
0.00%
Q1 2021$665,000
+13.1%
107,200
-7.2%
0.00%
Q4 2020$588,000
+8.7%
115,461
-5.8%
0.00%
Q3 2020$541,000
-32.6%
122,612
-16.0%
0.00%
Q2 2020$803,000
-9.1%
146,0210.0%0.00%
Q1 2020$883,000
-34.9%
146,021
-1.5%
0.00%
Q4 2019$1,357,000
+5.8%
148,283
+5.3%
0.00%
Q3 2019$1,283,000
-8.7%
140,853
+1.1%
0.00%
-100.0%
Q2 2019$1,406,000
-24.7%
139,353
+4.7%
0.00%0.0%
Q1 2019$1,868,000
-10.5%
133,137
+1.2%
0.00%0.0%
Q4 2018$2,087,000
-16.0%
131,537
-0.4%
0.00%0.0%
Q3 2018$2,484,000
-1.1%
132,070
+1.2%
0.00%0.0%
Q2 2018$2,512,000
-6.5%
130,555
+0.5%
0.00%0.0%
Q1 2018$2,687,000
+5.0%
129,952
+4.4%
0.00%0.0%
Q4 2017$2,558,000
+15.9%
124,429
+3.9%
0.00%0.0%
Q3 2017$2,208,000
-16.1%
119,779
+13.5%
0.00%0.0%
Q2 2017$2,633,000
+42.0%
105,523
+14.1%
0.00%0.0%
Q1 2017$1,854,000
-5.6%
92,445
+16.2%
0.00%0.0%
Q4 2016$1,964,000
+64.9%
79,585
+32.6%
0.00%0.0%
Q3 2016$1,191,000
+70.4%
60,012
+17.9%
0.00%
Q2 2016$699,000
+5.1%
50,906
+5.3%
0.00%
Q1 2016$665,000
+38.0%
48,329
+1.7%
0.00%
Q4 2015$482,000
+0.6%
47,5190.0%0.00%
Q3 2015$479,000
-30.9%
47,519
+1.7%
0.00%
Q2 2015$693,000
-6.7%
46,719
+4.4%
0.00%
Q1 2015$743,000
+10.2%
44,7390.0%0.00%
Q4 2014$674,000
+5.0%
44,739
-0.8%
0.00%
Q3 2014$642,000
+0.5%
45,1040.0%0.00%
Q2 2014$639,000
-18.0%
45,104
-0.9%
0.00%
-100.0%
Q1 2014$779,000
+16.6%
45,5040.0%0.00%0.0%
Q4 2013$668,000
+6.4%
45,504
-4.0%
0.00%0.0%
Q3 2013$628,000
+17.6%
47,404
-4.7%
0.00%0.0%
Q2 2013$534,00049,7540.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 44,501$218,2630.12%
Cannell Capital 74,794$366,8420.07%
SANTA MONICA PARTNERS LP 20,000$980.07%
RBF Capital, LLC 144,231$707,0000.05%
CRAWFORD INVESTMENT COUNSEL INC 257,795$1,264,4050.03%
Ancora Advisors LLC 70,916$3480.01%
WEDBUSH SECURITIES INC 30,928$1520.01%
Renaissance Technologies 290,463$1,4250.00%
GEODE CAPITAL MANAGEMENT, LLC 35,206$1730.00%
NORTHERN TRUST CORP 17,030$83,5270.00%
View complete list of PSYCHEMEDICS CORP shareholders